Nafarelin vs Follitropin alfa

Head-to-head comparison of Nafarelin (Nafarelin acetate) and Follitropin alfa (Recombinant Human Follicle-Stimulating Hormone Alfa) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyNafarelinFollitropin alfa
CategorySexual HealthSexual Health
Full NameNafarelin acetateRecombinant Human Follicle-Stimulating Hormone Alfa
Molecular Weight1321.47 Da30,000 Da
Half-Life~2-4 hours~24 hours
Amino Acids10N/A
Typical Dose200 mcg intranasal twice daily75-150 IU per dose
RouteIntranasalSubcutaneous/Intramuscular
Purity≥98%≥98%
Studies Count220850
Research StatusClinicalClinical

Nafarelin Benefits

  • pituitary suppression
  • cycle scheduling
  • endometriosis-related reproductive care
  • controlled hormone modulation

Follitropin alfa Benefits

  • supports spermatogenesis
  • improves Sertoli cell signaling
  • may enhance sperm parameters
  • complements LH-driven testosterone support

Nafarelin Dosing

200 mcg intranasal twice daily|0.4 mg/day intranasal|protocol-based suppression cycles

Follitropin alfa Dosing

75-150 IU SC/IM 2-3x weekly|adjust based on FSH and semen analysis|often combined with hCG in men

Nafarelin Side Effects

  • nasal irritation
  • hot flashes
  • headache

Follitropin alfa Side Effects

  • injection-site reactions
  • headache
  • bloating

Research Overview

Nafarelin

Nafarelin has a long history in reproductive medicine, especially for endometriosis and cycle suppression. Studies show it down-regulates the HPG axis after an initial stimulatory flare.

Follitropin alfa

Clinical literature supports follitropin alfa for male infertility, especially when combined with LH activity to optimize testicular output. Its role is strongest in hypogonadotropic hypogonadism and assisted reproduction protocols.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Nafarelin stacks with:

FSHhCG

Follitropin alfa stacks with:

hCGLutropin alfa
GnRH-agonistfertilityendocrinologyFSHgonadotropinclinical